Store
In Vitro Diagnostics (IVD) Market in China, 4th Edition
Publication Date: September 29, 2021
Tags: APAC, Asia, China, Coagulation, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 140
SKU: 21-036
As an in vitro diagnostics (IVD) market, China ranks just behind the large, developed economies of the United States, Western Europe, and Japan. The Chinese healthcare system faces challenges similar to those in less developed countries, alongside burdens common in affluent countries such as diabetes, cardiovascular disease, and aging-related diseases. China’s potential as an IVD market is significant, standing alongside other populous countries with strong economic growth over the past decade, such as Brazil, Russia, and India (collectively with China referred to as the BRIC nations).
Scope:
The Kalorama Information report, In Vitro Diagnostics (IVD) Market in China, 4th Edition, offers a comprehensive overview of the Chinese laboratory market and its key drivers. The focus is on the IVD sector, including reagents, consumables, calibrators, and controls across the following sub-segments:
- Clinical Chemistry: Routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC), including urinalysis and blood chemistry testing.
- Immunoassays: Hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology, and common infectious diseases (HIV, hepatitis, influenza).
- Microbiology and Molecular Testing: Manual and automated tests, culture media (prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
- Point-of-Care Testing: All POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases, including POC and non-POC blood gas and electrolytes, and glucose self-monitoring tests.
- Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
The report includes industry trends and country-level data such as disease incidence, life expectancy, population demographics, economic status, healthcare utilization, and other market influences.
Market Data:
All market data relates to the IVD market in China at the manufacturers’ level. Data is presented for the year 2021, with forecast data extending to 2026. Compound annual growth rates (CAGRs) are provided for the 2021-2026 period.
Explore the growth potential and dynamics of the Chinese IVD market with this detailed report, designed to offer valuable insights for market participants and stakeholders.
Table: Per Capita IVD Expenditures, by China Province/Region, 2021 ($ millions)
| Chinese Province/Region | Per Capita IVD Expenditures $ | Estimated IVD Market Size (millions USD) |
| Guangdon | $XX | $XX Million |
| Shangdon | $XX | $XX Million |
| Henan | $XX | $XX Million |
| Jiangsu | $XX | $XX Million |
| Sichuan | $XX | $XX Million |
| Hebei | $XX | $XX Million |
| Hunan | $XX | $XX Million |
| Zhejiang | $XX | $XX Million |
| Hubei | $XX | $XX Million |
| Anhui | $XX | $XX Million |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Chapter One: Executive Summary
Introduction
- Figure 1-1: Market Drivers and Restraints: IVD Market in China
Scope and Methodology
Major Findings of the Report
IVD Market in China
- Figure 1-2: China IVD Market, 2021 and 2026 ($ millions)
Chapter Two: China in Context
Overview
- Figure 2-1: China IVD Market vs. China Medical Device Market, 2021-2026
- Figure 2-2: China Market Dynamics
Population Trends
- Table 2-1: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
- Figure 2-3: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
- Figure 2-4: Total Number of Births in China by Year, 1990-2010 and Forecast 2020-2050
- Figure 2-5: China Life Expectancy at Birth in Years, 2010-2050
- Table 2-2: Elderly Dependency Ratio in China and Other Select Countries, 2010 and 2050
Disease Demographics
Diabetes
- Figure 2-6: Diabetes Prevalence, Top 10 Countries (number of adults age 20-79 years)
Cancer
- Table 2-3: Top 5 Cancers Affecting Chinese Population (ranked by total number of cases), 2020
Cardiovascular Disease
Infectious Disease Threats
Hepatitis
HIV/AIDS
Tuberculosis
COVID-19
Other Respiratory Diseases
Chinese Economy
- Figure 2-7: China GDP, GDP (PPP) and Health Spending Growth (CAGR 2005-2010, CAGR 2010-2015, CAGR 2015-2020)
- Figure 2-8: China GDP, GDP (PPP) and Health Spending, 1990-2020 (billions of $)
Chapter Three: Clinical Laboratory Structure in China
Clinical Laboratory Tests
Test Types
- Table 3-1: Types of IVD and Clinical Laboratory Tests, 2021
Venues for Test Usage
- Figure 3-1: Clinical Laboratory Service Market Distribution of Sales by Provider Type (China, United States, World), 2020
- Hospitals
- Figure 3-2: Utilization of Beds in Medical Institutions: China’s Average Length of Stay is Increasing Slightly, 1985-2018
- Figure 3-3: China Health Care Institutions by Type (2005, 2010, 2015, 2018)
- Figure 3-4: Number of Visits and Admissions to Hospital Institutions in China Annually, 2018
- Private Laboratories
Urban vs. Rural IVD Market
- Table 3-2: China In Vitro Diagnostic Reagent Sales by Urban/Rural Environment, 2021
- Figure 3-5: Province-level Administrative Divisions of China
- Table 3-3: Per Capita IVD Expenditures by China Province/Region, 2021
- Figure 3-6: China IVD Market by Province/Region
Chinese Healthcare Reform and Hospital Infrastructure
- Comprehensively deepen medical and health system reform
- Improve the universal medical security system
- Strengthen major critical disease prevention and control and basic public health service
- Strengthen maternal and child healthcare and reproductive services
- Improve the medical service system
- Push for traditional Chinese medicine inheritance and development
- Widely carry out public fitness campaigns
- Ensure food and drug safety
China Regulation and Medical Device Policy Challenges
Distribution in China
Medical Device Regulation Overview: China
Chapter Four: IVD Markets in China
Market Introduction and Summary
- Table 4-1: China In Vitro Diagnostic Sales by Market Segment, 2021-2026 ($ millions)
- Figure 4-1: China In Vitro Diagnostic Sales by Market Segment, 2021-2026 ($ millions)
- Figure 4-2: China In Vitro Diagnostic Sales by Market Segment, 2021 Market Distribution (%)
Clinical Chemistry
- Figure 4-3: China – Clinical Chemistry IVD Market, 2021-2026
- Types of Tests
- Table 4-2: China – Clinical Chemistry IVD Market Distribution, 2021-2026 (%)
- Figure 4-4: China – Clinical Chemistry IVD Market Value by Segment, 2021 vs. 2026
- Clinical Chemistries
Point-of-Care (POC) Testing
- Figure 4-5: China – Point-of-Care IVD Market, 2021-2026
- Types of Tests
- Table 4-3: China – Point-of-Care IVD Market Distribution, 2021-2026 (%)
- Figure 4-6: China – Point-of-Care IVD Market Value by Segment, 2021 vs. 2026
Immunoassays
- Figure 4-7: China – Immunoassay IVD Market, 2021-2026
- Types of Tests
- Table 4-4: China – Immunoassay IVD Market Distribution, 2021-2026 (%)
- Figure 4-8: China – Immunoassay IVD Market Value by Segment, 2021 vs. 2026
Molecular Assays
- Figure 4-9: China – Molecular Assay IVD Market, 2021-2026
- Types of Tests
- Table 4-5: China – Molecular Assay IVD Market Distribution, 2021-2026 (%)
- Figure 4-10: China – Molecular Assay IVD Market Value by Segment, 2021 vs. 2026
- Tests for Infectious Disease
- Table 4-6: HIV Statistics in China, 2020
- Tests for Cancer
- Tests for Genetic Diseases
- Other Tests
Hematology
- Figure 4-11: China – Hematology IVD Market, 2021-2026
- Types of Tests
Coagulation
- Figure 4-12: China – Coagulation IVD Market, 2021-2026
- Types of Tests
Microbiology
- Table 4-7: China Infectious Disease Classification Tier
- Figure 4-13: China – Microbiology IVD Market, 2021-2026
- Types of Tests
- Table 4-8: China – Microbiology IVD Market Distribution, 2021-2026 (%)
- Figure 4-14: China – Microbiology IVD Market Value by Segment, 2021 vs. 2026
Tests Used in Blood Banking
- Figure 4-15: China – Blood Bank Test IVD Market, 2021-2026
- Table 4-9: Prevalence of Transfusion-transmissible Infections in Blood Donations (Median, Interquartile range (IQR), by Income Group
- Types of Tests
Histology and Cytology
- Figure 4-16: China – Histology/Cytology IVD Market, 2021-2026
- Types of Tests
- Table 4-10: China – Histology/Cytology IVD Market Distribution, 2021-2026 (%)
- Figure 4-17: China – Histology/Cytology IVD Market Value by Segment, 2021 vs. 2026
- Pap Stains
- Traditional Non-Pap Stains
- Immunohistochemistry and In Situ Hybridization
- Circulating Tumor Cells
Prenatal and Genetic Test Services
Chapter Five: Company Activity in China
China IVD Market Participant Overview
- Figure 5-1: China Market Share, Major Global IVD Vendors, 2020 IVD Sales Distribution by Company
Abbott Laboratories
Arkray
Becton, Dickinson & Co.
bioMérieux, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corp.
Hologic, Inc.
Horiba Medical
Instrumentation Laboratory
Luminex Corporation
Mindray Medical International, Ltd.
Myriad Genetics
Ortho Clinical Diagnostics
PerkinElmer
Qiagen N.V.
Roche
Siemens Healthineers
Sysmex Corp.
Thermo Fisher Scientific
Appendix: Sources of Information
Related products
30-Country IVD Market Atlas, 2026 – July Update
July 20, 2026
Kalorama’s 30-Country IVD Market Atlas sizes and forecasts the in vitro diagnostics market across 30 key countries and 18 segments, with five-year projections through 2030 and country-level revenue data updated through June 2026.
Price range: $5,600.00 through $8,000.00
30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025
December 19, 2025
Updated December 2025
Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030,…
Price range: $5,600.00 through $8,000.00
In Vitro Diagnostics (IVD) in India
June 30, 2022
Kalorama Information is proud to announce a comprehensive new market research report, offering an in-depth overview of the In Vitro Diagnostics (IVD) market in India. This report delves into the IVD discipline, covering reagents, consumables, calibrators, and controls across various sub-segments, providing a detailed analysis of market trends and influences.
Report Highlights:
- Clinical…
Price range: $4,000.00 through $6,000.00
